Technical Diligence.

Technical Diligence.

Risk clarity for capital allocators.

Risk clarity for capital allocators.

What We Evaluate

What We Evaluate

What We Evaluate

Scientific and technical deep-dives to separate robust claims from wishful thinking.

Scientific and technical deep-dives to separate robust claims from wishful thinking.

Our team comprises:
PhDs in the fields of Chemistry,

Materials Science, Tissue Engineering, Biomedical

Engineering, NeuroEngineering, Biology.


Clinicians, Physicians and Surgeons


Venture Capitalists, Software Engineers


IP/Patent Attorneys

Our team researches:
Science and Medical feasibility


Regulatory and Commercialization hurdles


Business Model and Economics


Competitive Analysis

What You Get

What You Get

What You Get

Regulatory, product-market, and execution risks surfaced early, not after the check clears.

Regulatory, product-market, and execution risks surfaced early, not after the check clears.

Questions answered

Questions answered

Questions answered

Real-world validation on market fit, differentiated IP, and scaling potential.

Real-world validation on market fit, differentiated IP, and scaling potential.

Our team answers:
How much lead time a company has?


Is there research in universities that a

company doesn't know of?


Are the materials and devices on the rising

edge of adoption or falling?


Will surgeons use such technology?


Will hospitals create friction?

Unbiased diligence.

Operator-led insights into what works, what doesn’t, and what’s risky.

Operator-led insights into what works, what doesn’t, and what’s risky.

Operator-led insights into what works, what doesn’t, and what’s risky.

Clear deliverables.

Risk reports, diligence memos, and actionable recommendations.

Experience

Astute Crew founders are also founders/advisors of a neurotech device VC fund— where they validate technology.

They also work on opportunities where startups want to expand into other countries.

Engagement Model

Direct access to senior operators—no salespeople or juniors. We prioritize clear communication, quick onboarding, and milestones tied to investor timelines.

Start with a quick scoping call. We tailor our diligence or review to your needs and build a focused analytical plan.

You receive an actionable risk map, operator perspective, and direct recommendations—designed for urgency, depth, and high-stakes capital deployment.